Clinical Trial Update: Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating long-term safety and efficacy of evinacumab in homozygous familial hypercholesterolemia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Evkeeza (evinacumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2024-04-30